TP53 and hepatocellular carcinoma: In the TP53 pathway, miR-155 represses SOX6 to reduce its role in upregulating tumor suppressor expression of p21/Waf1/cip1 thus promoting reduced cell cycle controls and promoting HCC proliferation [8,224].